mCRPC (Metastatic Castration-resistant Prostate Cancer) trials recruiting in Nebraska

All mCRPC (Metastatic Castration-resistant Prostate Cancer) trials nationally

Cities in Nebraska

Recruiting trials in Nebraska

• A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
  NCT06785636 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · Nebraska: Omaha
• A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT07581184 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Nebraska: Omaha
• Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
  NCT06801236 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · Nebraska: Omaha
• Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
  NCT05283330 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Nebraska: Omaha